3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Anus Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
SCLC, Extensive Stage
1
SCLC
1
Retinoblastoma
1
Retinal Neoplasms
1
Recurrence
1
Radiation Therapy
1
Prostatic Neoplasms
1
Interventions
pembrolizumab
4
Oxaliplatin
4
zolbetuximab
2
camrelizumab
2
apatinib
2
S 1 (combination)
2
Paclitaxel
2
Nivolumab
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tislelizumab
1
tepotinib
1
relugolix
1
regorafenib
1
lenvatinib
1
durvalumab
1
dabrafenib
1
cemiplimab
1
cabazitaxel
1
alpha-2'-deoxythioguanosine
1
X-Rays
1
Vinorelbine
1
Trifluridine
1
Surveys and Questionnaires
1
Ramucirumab
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Adenocarcinoma
×
Drug Therapy
×
Clear all
NCT06504615
2026-04-03
METAGIO
Bristol-Myers Squibb
Active not recruiting
208 enrolled